Nasdaq · CIK 0000898437
ANIK Anika Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Jun 24, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
12
with a Form 4 at this company
Signals
Open-market buys and sells at Anika Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 46 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Sheryl L Conley director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 42,568 | Jun 24, 2025 |
| Jun 20, 2025 | Gary P Fischetti director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 41,613 | Jun 24, 2025 |
| Jun 20, 2025 | John B Henneman III director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 49,871 | Jun 24, 2025 |
| Jun 20, 2025 | William R Jellison director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 20,403 | Jun 24, 2025 |
| Jun 20, 2025 | Glenn R. Larsen director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 50,258 | Jun 24, 2025 |
| Jun 20, 2025 | Stephen Richard director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 47,871 | Jun 24, 2025 |
| Jun 20, 2025 | Susan L N Vogt director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 50,213 | Jun 24, 2025 |
| Jun 20, 2025 | Joseph H Capper director | AGrant or award Common Stock | +14,164 | $0.00 | $0 | 20,403 | Jun 24, 2025 |
| Jun 3, 2025 | Stephen D. Griffin EVP, CFO & COO | MOption exercise Common Stock | +12,840 | $0.00 | $0 | 13,640 | Jun 5, 2025 |
| Jun 3, 2025 | Stephen D. Griffin EVP, CFO & COO | FTax withholding Common Stock | -3,769 | $11.59 | $44k | 9,871 | Jun 5, 2025 |
| Jun 3, 2025 | Stephen D. Griffin EVP, CFO & COO | MOption exercise Restricted Stock Unitderivative | +12,840 | $0.00 | $0 | 25,680 | Jun 5, 2025 |
| Mar 17, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Common Stock | +25,132 | $0.00 | $0 | 209,472 | Mar 18, 2025 |
| Mar 14, 2025 | Stephen D. Griffin EVP, CFO and Treasurer | AGrant or award Restricted Stock Unitderivative | +38,473 | $0.00 | $0 | 38,473 | Mar 18, 2025 |
| Mar 17, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Common Stock | +3,637 | $0.00 | $0 | 21,722 | Mar 18, 2025 |
| Mar 17, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Common Stock | +6,448 | $0.00 | $0 | 49,847 | Mar 18, 2025 |
| Mar 17, 2025 | David Colleran EVP, General Counsel, Corp Sec | FTax withholding Common Stock | -1,893 | $15.91 | $30k | 47,954 | Mar 18, 2025 |
| Mar 17, 2025 | Anne Nunes SVP, Chief Operations Officer | FTax withholding Common Stock | -1,068 | $15.91 | $17k | 20,654 | Mar 18, 2025 |
| Mar 14, 2025 | Stephen D. Griffin EVP, CFO and Treasurer | AGrant or award Restricted Stock Unitderivative | +18,672 | $0.00 | $0 | 18,672 | Mar 18, 2025 |
| Mar 17, 2025 | Cheryl R Blanchard President, CEO, Director | FTax withholding Common Stock | -12,152 | $15.91 | $193k | 197,320 | Mar 18, 2025 |
| Mar 14, 2025 | Anne Nunes SVP, Chief Operations Officer | AGrant or award Restricted Stock Unitderivative | +20,761 | $0.00 | $0 | 20,761 | Mar 18, 2025 |
| Mar 14, 2025 | David Colleran EVP, General Counsel, Corp Sec | AGrant or award Restricted Stock Unitderivative | +28,165 | $0.00 | $0 | 28,165 | Mar 18, 2025 |
| Mar 14, 2025 | Anne Nunes SVP, Chief Operations Officer | AGrant or award Restricted Stock Unitderivative | +4,650 | $0.00 | $0 | 4,650 | Mar 18, 2025 |
| Mar 14, 2025 | David Colleran EVP, General Counsel, Corp Sec | AGrant or award Restricted Stock Unitderivative | +13,669 | $0.00 | $0 | 13,669 | Mar 18, 2025 |
| Mar 14, 2025 | Cheryl R Blanchard President, CEO, Director | AGrant or award Restricted Stock Unitderivative | +73,559 | $0.00 | $0 | 73,559 | Mar 18, 2025 |
| Mar 17, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Restricted Stock Unitderivative | -3,637 | $0.00 | $0 | 7,275 | Mar 18, 2025 |
| Mar 17, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Restricted Stock Unitderivative | -6,448 | $0.00 | $0 | 12,897 | Mar 18, 2025 |
| Mar 14, 2025 | Cheryl R Blanchard President, CEO, Director | AGrant or award Restricted Stock Unitderivative | +71,403 | $0.00 | $0 | 71,403 | Mar 18, 2025 |
| Mar 17, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Restricted Stock Unitderivative | -25,132 | $0.00 | $0 | 50,263 | Mar 18, 2025 |
| Mar 11, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Common Stock | +2,561 | $0.00 | $0 | 18,837 | Mar 13, 2025 |
| Mar 11, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Common Stock | +7,663 | $0.00 | $0 | 45,649 | Mar 13, 2025 |
| Mar 11, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Common Stock | +30,060 | $0.00 | $0 | 197,015 | Mar 13, 2025 |
| Mar 11, 2025 | Cheryl R Blanchard President, CEO, Director | FTax withholding Common Stock | -12,675 | $16.79 | $213k | 184,340 | Mar 13, 2025 |
| Mar 11, 2025 | David Colleran EVP, General Counsel, Corp Sec | FTax withholding Common Stock | -2,250 | $16.79 | $38k | 43,399 | Mar 13, 2025 |
| Mar 11, 2025 | Anne Nunes SVP, Chief Operations Officer | FTax withholding Common Stock | -752 | $16.79 | $13k | 18,085 | Mar 13, 2025 |
| Mar 11, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Restricted Stock Unitderivative | -7,663 | $0.00 | $0 | 0 | Mar 13, 2025 |
| Mar 11, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Restricted Stock Unitderivative | -2,561 | $0.00 | $0 | 0 | Mar 13, 2025 |
| Mar 11, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Restricted Stock Unitderivative | -30,060 | $0.00 | $0 | 0 | Mar 13, 2025 |
| Mar 10, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Common Stock | +20,002 | $0.00 | $0 | 172,826 | Mar 11, 2025 |
| Mar 10, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Common Stock | +5,465 | $0.00 | $0 | 39,590 | Mar 11, 2025 |
| Mar 10, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Common Stock | +3,296 | $0.00 | $0 | 17,235 | Mar 11, 2025 |
| Mar 10, 2025 | Cheryl R Blanchard President, CEO, Director | FTax withholding Common Stock | -5,871 | $16.62 | $98k | 166,955 | Mar 11, 2025 |
| Mar 10, 2025 | David Colleran EVP, General Counsel, Corp Sec | FTax withholding Common Stock | -1,604 | $16.62 | $27k | 37,986 | Mar 11, 2025 |
| Mar 10, 2025 | Anne Nunes SVP, Chief Operations Officer | FTax withholding Common Stock | -959 | $16.62 | $16k | 16,276 | Mar 11, 2025 |
| Mar 10, 2025 | David Colleran EVP, General Counsel, Corp Sec | MOption exercise Restricted Stock Unitderivative | -5,465 | $0.00 | $0 | 5,465 | Mar 11, 2025 |
| Mar 10, 2025 | Anne Nunes SVP, Chief Operations Officer | MOption exercise Restricted Stock Unitderivative | -3,296 | $0.00 | $0 | 3,295 | Mar 11, 2025 |
| Mar 10, 2025 | Cheryl R Blanchard President, CEO, Director | MOption exercise Restricted Stock Unitderivative | -20,002 | $0.00 | $0 | 20,001 | Mar 11, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Cheryl R BlanchardPresident, CEO, Director
- Sheryl L Conleydirector
- Joseph H Capperceo, officer, director
- David ColleranEVP, General Counsel, Corp Sec
- Gary P Fischettidirector
- Stephen D. GriffinEVP, CFO & COO
- John B Henneman IIIdirector
- William R Jellisondirector
- Glenn R. Larsendirector
- Anne NunesSVP, Chief Operations Officer
- Stephen Richarddirector
- Susan L N Vogtdirector
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.